Article info
Therapeutics/Prevention
Randomised controlled trial
Cannabinoids fail to show evidence of slowing down the progression of multiple sclerosis
- Correspondence to : Dr Gareth Pryce, Centre for Neuroscience, Blizard Institute, Barts and The London School of Medicine and Dentistry, QMUL, 4 Newark Street, London E1 2AT, UK; g.pryce{at}qmul.ac.uk
Citation
Cannabinoids fail to show evidence of slowing down the progression of multiple sclerosis
Publication history
- First published April 20, 2015.
Online issue publication
November 05, 2018
Article Versions
- Previous version (5 November 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions